SLC7A5 and glioma: As LAT1 overexpression has been correlated with malignant phenotype and proliferation of gliomas, this new AA tracer could possibly demonstrate value for guiding biopsy, diagnosing primary brain tumor, tumor grading, directing radiotherapy, or even for discriminating between tumor recurrence and radionecrosis after initial therapy42,43.